K242685

Substantially Equivalent

Atellica® CH Creatinine_3 (Crea3)

Applicant: Siemens Healthcare Diagnostics, Inc.
Product code: CGX
Advisory panel: Clinical Chemistry
Date received: 2024-09-06
Decision date: 2024-12-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.